Market Cap 44.44M
Revenue (ttm) 84.51M
Net Income (ttm) -60.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -71.75%
Debt to Equity Ratio -4.12
Volume 230,500
Avg Vol 313,998
Day's Range N/A - N/A
Shares Out 27.61M
Stochastic %K 19%
Beta 1.82
Analysts Strong Sell
Price Target $15.33

Latest News on FBIO

Sun Pharma to Acquire Checkpoint Therapeutics

Mar 9, 2025, 10:06 PM EDT - 25 days ago

Sun Pharma to Acquire Checkpoint Therapeutics

CKPT